Patents by Inventor Dipak K. Banerjee

Dipak K. Banerjee has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Anti-angiogenic therapeutics efficacy enhanced by nanoformulation
    Patent number: 8524685
    Abstract: Preparation of nano-conjugated Tunicamycin enhances the efficacy of the drug Tunicamycin. The invention provides several nanoformulations such as Tunicamycin encapsulated in peptide nanotubes, nanotubes bound to gold nanoparticles conjugated with Tunicamycin, Tunicamycin conjugated with nanotubes, gold nanoparticles bound to tubes and conjugated with Tunicamycin, and gold nanoparticles conjugated with Tunicamycin.
    Type: Grant
    Filed: November 7, 2011
    Date of Patent: September 3, 2013
    Assignee: University of Puerto Rico
    Inventor: Dipak K Banerjee
  • Methods for inhibiting angiogenesis
    Patent number: 7361643
    Abstract: A method for inhibiting angiogenesis, including: administering a nucleoside, such as tunicamycin, in an amount effective to inhibit angiogenesis, to a patient in need of such treatment. A method for inhibiting angiogenesis, including: administering a nucleoside, which comprises glucosamine, in an amount effective to inhibit angiogenesis, to a patient in need of such treatment; wherein the nucleoside is administered for a period of time, subsequently the administration of the nucleoside is suspended for a period of time of at least about 1 week, and subsequently the administration of the nucleoside is resumed.
    Type: Grant
    Filed: February 9, 2001
    Date of Patent: April 22, 2008
    Assignee: University of Puerto Rico
    Inventors: Dipak K. Banerjee, Juan A. Martinez
  • Methods for inhibiting angiogenesis
    Publication number: 20020160979
    Abstract: A method for inhibiting angiogenesis, including: administering a nucleoside, such as tunicamycin, in an amount effective to inhibit angiogenesis, to a patient in need of such treatment. A method for inhibiting angiogenesis, including: administering a nucleoside, which comprises glucosamine, in an amount effective to inhibit angiogenesis, to a patient in need of such treatment; wherein the nucleoside is administered for a period of time, subsequently the administration of the nucleoside is suspended for a period of time of at least about 1 week, and subsequently the administration of the nucleoside is resumed.
    Type: Application
    Filed: February 9, 2001
    Publication date: October 31, 2002
    Inventors: Dipak K. Banerjee, Juan A. Martinez